[Results of the TRIZAL Study. Therapy change with positive concomitant effect].
D019380:Anti-HIV Agents / Q000008:administration & dosage* / Q000009:adverse effects; D002784:Cholesterol / Q000097:blood; D002986:Clinical Trials as Topic; D015224:Dideoxynucleosides / Q000008:administration & dosage* / Q000009:adverse effects; D004338:Drug Combinations; D015658:HIV Infections / Q000097:blood / Q000188:drug therapy*; D006801:Humans; D019259:Lamivudine / Q000008:administration & dosage* / Q000009:adverse effects; D016896:Treatment Outcome; D014280:Triglycerides / Q000097:blood; D015215:Zidovudine / Q000008:administration & dosage* / Q000009:adverse effects; D000099227:Abacavir
D019380:Anti-HIV Agents; D002784:Cholesterol; D015224:Dideoxynucleosides; D004338:Drug Combinations; D019259:Lamivudine; D014280:Triglycerides; D015215:Zidovudine; C418262:abacavir, lamivudine, and zidovudine drug combination; D000099227:Abacavir